Publications by authors named "Matthias Goebel"

Claim this Profile
C
Characterization of telmisartan-derived PPARγ agonists: importance of moiety shift from position 6 to 5 on potency, efficacy and cofactor recruitment.
Lena Herbst, Matthias Goebel, Sebastian Bandholtz, Ronald Gust, Ulrich Kintscher

ChemMedChem· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study.
Roland E Schmieder, Matthias Goebel, Peter Bramlage

Vasc Health Risk Manag· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of new PPARgamma agonists: benzimidazole derivatives-importance of positions 5 and 6, and computational studies on the binding mode.
Matthias Goebel, Gerhard Wolber, Patrick Markt, Bart Staels, Thomas Unger

Bioorg Med Chem· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic treatment with losartan results in sufficient serum levels of the metabolite EXP3179 for PPARgamma activation.
Kai Kappert, Oleg Tsuprykov, Jan Kaufmann, Jan Fritzsche, Ingo Ott, Matthias Goebel

Hypertension· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of new PPARgamma agonists: benzimidazole derivatives - the importance of position 2.
Matthias Goebel, Bart Staels, Thomas Unger, Ulrich Kintscher, Ronald Gust

ChemMedChem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INT-131, a PPARgamma agonist for the treatment of type 2 diabetes.
Ulrich Kintscher, Matthias Goebel

Curr Opin Investig Drugs· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of new PPARgamma agonists: analysis of telmisartan's structural components.
Matthias Goebel, Markus Clemenz, Bart Staels, Thomas Unger, Ulrich Kintscher

ChemMedChem· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren.
Jan H Schefe, Christian Neumann, Matthias Goebel, Jan Danser, Sebastian Kirsch

J Hypertens· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartan.
Matthias Goebel, Markus Clemenz, Thomas Unger

Expert Rev Cardiovasc Ther· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis